Reduced atrial angiotensin receptor type 1 mRNA content in end-stage human heart failure: Assessment by a novel quantitative PCR-ELISA technique

Journal of Molecular Medicine

Volumn 74, Issue 8, 1996, Pages 447-454

  Bauer, P ^a   Regitz Zagrosek, V ^a   Hofmeister, J ^b   Lokies, J ^a   Rolfs, A ^c   Hildebrandt, A G ^d   Hetzer, R ^b   Fleck, E ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^c UNIVERSITY OF ROSTOCK   (Germany)

^d Bundesinstitut für Arzneimittel   (Germany)

Author keywords

Angiotensin receptora; Human Atrium; mRNA; quantitative PCR

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART ATRIUM; HEART FAILURE; HEART HYPERTROPHY; HEART INFARCTION; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; MALE; POLYMERASE CHAIN REACTION; REPRODUCIBILITY;

EID: 0029780835     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00217520     Document Type: Article

References (23)

1. Dostal DE, Baker KM (1992) Angiotensin II stimulation of left ventricular hypertrophy in adult rat heart. Am J Hypertens 5:276-280
2. Linz W SB Lindpaintner K, Ganten D (1989) Cardiac renin angiotensin system. Am J Hypertension 2:301-10
3. Pfeffer MA, Lamas GA, Vaughan DE, Parisi AF, Braunwald E (1988) Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med 319:80-86
4. Pfeffer MA, Braunwald E, Moye LA et al (1992) Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE investigators. N Engl J Med 327:669-677
5. Rogers T (1984) High affinity angiotensin II receptors in myocardial sarcolemmal membranes. J Biol Chem 259:8106-8114
6. Villarreal FJ, Kim NN, Ungab GD, Printz MP, Dillmann WH (1993) Identification of functional angiotensin II receptors on rat cardiac fibroblasts. Circulation 88:2849-2861
7. Schorb W, Booz, GW, Dostal DE, Conrad KM, Chang KC, Baker KM (1993) Angiotensin II its mitogenic in neonatal rat cardiac fibroblasts. Circ Res 72:1245-1254
8. Holubarsch C, Hasenfuss G, Schmidt-Schweda S et al (1993) Angiotensin I and II exert inotropic effects in atrial but not in ventricular human myocardium. Circulation 88:1228-1237
9. Weber KT, Sun Y, Guarda E et al (1995) Myocardial fibroblasts in hypertensive heart disease: an overview of potential regulatory mechanisms. Eur Heart J 16:24-28
10. Neuß M, Hildebrandt AG, Regitz-Zagrosek V, Fleck E (1994) Human cardiac fibroblasts express an angiotensin receptor with unusual binding characteristics which is coupled to cellular proliferation. Biochem Biophys Res Comm 204:1334-1339
11. Regitz-Zagrosek V, Friedel N, Heymann A et al (1995) Regulation, chamber localization, and subtype distribution of angiotensin II receptors in human hearts. Circulation 91:1461-1471
12. Bauer P, Rolfs A, Regitz-Zagrosek V, Hildebrandt A, Fleck E (1996) MMLV reverse transcriptase creates PCR artifacts after effective DNase I digestion. Biotechniques (in press)
13. Bauer P (1996) Regulation der mRNA des humanen Angiotensin II Rezeptors Subtyp 1 im menschlichen Myokard bei terminaler Herzinsuffizienz. Thesis, Free University of Berlin
14. 1-adrenergic receptors in the failing human heart. Circulation 87:454-463
15. Rolfs A (1992) Quantification of PCR products. In: Rolfs A, Schuller I, Finckh U, Weber-Rolfs I (eds) PCR: clinical diagnostics and research. Springer, Berlin Heidelberg New York, pp 201-207
16. Becker-André M, Hahlbrock K (1989) Absolute mRNA quantification using the polymerase chain reaction (PCR). A novel approach by a PCR aided transcript titration assay (PATTY) Nucleic Acids Res 17:9437-9446
17. Friedrich SP, Lorell BH, Rousseau MF et al (1994) Intracardiac angiotensin-converting enzyme inhibition improves diastolic function in patients with left ventricular hypertrophy due to aortic stenosis. Circulation 90:2761-2771
18. Haber HL, Powers ER, Gimple LW et al (1994) Intracoronary angiotensin-convering enzyme inhibition improves diastolic function in patients with hypertensive left ventricular hypertrophy. Circulation 89:2616-2625
19. Regitz-Zagrosek V, Bassewitz S, Hildebrandt AG, Fleck E (1995) Humane Angiotensin II Rezeptoren im rechten und linken Ventrikel gehören überwiegend dem Subtyp 2 an. Z Kardiol 84 [Suppl 1]:253
20. Bauer P, Linz W, Rasch A, Schoelkens B, Regitz-Zagrosek V, Fleck E (1996) Expression von Genen des Renin Angiotensin Systems bei Ratten mit Volumenbelastung durch aortokavalen Shunt. Z Kardiol 85 [Suppl 2]:280
21. Fielitz J, Regitz-Zagrosek V, Bauer P, Lokies J, Fleck E (1996) Ein Verlust an Angiotensinrezeptor Subtyp 1 (AT1) mRNA ist bei Herzinsuffizienz in rechtsventrikulären Endomyokardbiopsien nachweisbar. Z Kardiol 85 [Suppl 2]:98
22. Schunkert H, Weinberg EO, Bruckschlegel G, Riegger AJG, Lorell BH (1995) Alterations of growth responses in established cardiac pressure overload hypertrophy in rats with aortic banding. J Clin Invest 96:2768-2774
23. Regitz-Zagrosek V, Auch-Schwelk W, Hess B et al (1995) Tissue and subtype specific modulation of angiotensin II receptors by chronic treatment with cyclosporin A, ACE-inhibitors and AT1 antagonists. J Cardiovasc Pharmacol 26:66-72